Thats been, like, another big, concerning thing among clinicians cause when you think about weight loss, whether its through a GLP-1 drug, exercise, diet or something like malnutrition, youre losing all different, quote, unquote, types of weight
The regulator is essentially drawing a firm line: Build genuine HCP education and patient outcomes, not consumer-facing hype
But, you must consult with your doctor regarding the right dosage so there are no side effects
Distribution of medications was similar across cohort 1 and 2 and commonly included biguanides, sulfonylurea, and basal insulins
Patients taking Wegovy should monitor for alarm features that suggest more serious pathology: Unintentional weight loss beyond expected therapeutic weight reduction Difficulty swallowing (dysphagia) Persistent vomiting Evidence of gastrointestinal bleeding (black, tarry stools or blood in vomit) Severe, unrelenting abdominal pain, especially if radiating to the back (which may indicate pancreatitis) Right upper abdominal pain with or without fever/jaundice (which may indicate gallbladder disease) If you experience these symptoms whilst taking Wegovy, it is essential to contact your GP promptly for clinical assessment